VIDEO: Obama Adminstration preparing for mass H1NI vaccination across America

Press reports confirms the US government’s intent to implement a mass vaccination program in Fall-Winter of 2009.  A major contract for 160 million doses has been established with Big Pharma, enough to innoculate more than half of the US populaiton. Similar plans are ongoing in other Western countries including France, Canada, the UK. Volunteers are being recruited to test the swine flu vaccine. (see video below).

The Los Angeles Times has reassured the US public with an article entitled: What are the odds that H1N1 will kill you? 

“Federal health officials say the U.S. expects to have 160 million doses of swine flu vaccine available sometime in October if all goes well.

That’s despite continued bad production from manufacturers around the world. The chief ingredient for vaccine is grown in chicken eggs, and companies are getting far fewer doses per egg than is usual with regular winter flu.

Another complication: That 160 million estimate assumes a low dose will work. Studies will begin in a few weeks to see if this new vaccine will protect with a low dose or if people will need a higher one. Scientists also expect people will need two separate inoculations, about a month apart, for protection.” (AP, 22 July 2009)

The government has already called on volunteers: 

Video: Govt Calls for Volunteers to Test Swine Flu Shot


Comment on Global Research Articles on our Facebook page

Become a Member of Global Research

Articles by: Global Research

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected] contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]